Sponsors and Collaborators
Fernando C Fervenza, M.D., Ph.D.
Lori A Riess
- Age >18 years
- Proteinuria > 5g/24h despite ACEi and/or ARB treatment for > 3 months
- Estimated or quantified GFR > 40 ml/min/1.73m2 while taking ACEi/ARB therapy
- Resistant to cyclosporine (CSA) are excluded but patients who initially responded to CSA but relapsed off CSA are eligible for the study
Fernando C. Fervenza, M.D., Ph.D., Mayo Clinic